A Breakthrough Israeli Technology for Brain Rehabilitation
The neuroplastic helmet of BRAIN.Q enables an intensive daily brain rehabilitation process - from home, independently, at the time and pace suitable for each patient.


Proud to collaborate with esteemed research and medical institutions



.avif)



.avif)
Behind the Numbers — People, Families, and Moments Restored.
I think that first and foremost, the close and encouraging support system after the initial rehabilitation was something my mother was really missing… There was no framework that could enable my mother to create a different reality for herself. It felt like the system was giving up on such a large segment of the population… I am keeping my fingers crossed that you will bring this kind of light to so many others.
March 2026, Hadera
I really feel much stronger in my legs! I keep practicing many of these exercises because I feel that I am seeing results!
May 2026, Rishon LeZion
BrainQ gave me something to look forward to every day.
I have to share because I’m in tears… For the first time, *** stood on his weaker leg (with the other leg on a step) without hand support. I was so excited that I forgot to take a video.
May 2026, Netanya.
The years, patients, and experience behind the platform.
High Safety
No serious adverse events were reported throughout all clinical studies.
The findings are based on preliminary data from an ongoing clinical study. During the open-label phase (Day 90–180), participants received active treatment with the BRAIN.Q system up to five times per week. Improvement in functional status (mRS) was observed among participants who continued active treatment compared to those who did not.

The Patient as a Leading and Active Partner in the Rehabilitation Process

Steps to Begin Home-Based Rehabilitation
Initial Conversation
- Completion of the program eligibility assessment
- Introductory conversation and preliminary eligibility review
- Opening the eligibility process
Clinical Consultation Meeting
- Independent clinical evaluation
- Review of the medical profile for suitability to the program
- The eligibility decision is made at the independent discretion of the physician
Contract Signing and Start Date Scheduling
If clinical eligibility is confirmed:
- Contract signing
- Scheduling a home setup appointment
Home Setup Meeting
- A two-hour meeting with a clinician to adapt the program to the patient and family
- Full training and delivery of the system to the patient
Program Initiation and Ongoing Support
- Daily treatment guided by a dedicated clinician
- Periodic evaluations
- Ongoing adjustment of goals according to progress
Personalized. Clinically Guided. Scientifically Proven.
- Each patient receives close support from a personal treating clinician who has been carefully selected and specially trained on the system.
- In a presentation at the World Stroke Congress* (2026), which analyzed the overall results of the company’s clinical studies, a significant contribution of the electromagnetic field to influencing brain networks and achieving consistent functional improvement over time was demonstrated.
- The program is conducted in collaboration with leading neurological clinics in Israel.
- The program is based on a decade of clinical research and development.
- Continuous support enables dynamic adaptation of the program to each patient, as well as identification and resolution of challenges that arise along the way.
- The program is supervised by BRAIN.Q’s Medical Director, Dr. Jeffrey Saver, Director of the Stroke Center at UCLA and a world-renowned neurologist.
*The data are based on randomized controlled trials (RCTs) involving patients with moderate-to-severe subacute ischemic stroke.
*הנתונים מבוססים על מחקרים אקראיים מבוקרים (RCT) בקרב מטופלים עם שבץ איסכמי בינוני–קשה בשלב הסאב־אקוטי.
BRAIN.Q Medical Director
Program Cost
2,000 ILS
2,500 ILS
